by danka | Apr 10, 2024 | Speakers Biosimilars LatAm - Europe 2024
Blau Farmacêutica, Brazil RD&I Director Uilberson, is in charge of R&D area at Blau Farmacêutica in Brazil, leads the development of biosimilars for the Brazilian market and other Latin American countries. Its strategic scientific, regulatory and clinical...
by danka | Apr 10, 2024 | Speakers Biosimilars LatAm - Europe 2024
Teva Pharmaceuticals, Argentina Sr. Medical Director Cluster Medical Affairs LATAM & Argentina Pharmaceutical Medicine Specialist. More than 15 years of experience in the Pharmaceutical Industry in Medical Affairs and Clinical Research Departments. Currently...
by danka | Mar 20, 2024 | Speakers Biosimilars LatAm - Europe 2024
Sindusfarma, Brazil Access Manager Pharmacist, doctor in Pharmaceutical Sciences, specialist in health administration, and economics and HTA. She worked as coordinator of municipal pharmaceutical assistance for 3 years, and for 9 years worked as technical consultant...
by danka | Mar 13, 2024 | Speakers Biosimilars LatAm - Europe 2024
CANIFARMA, Mexico General Director Register for the Biosimilars LatAm – Europe 2024 Back
by danka | Mar 8, 2024 | Speakers Biosimilars LatAm - Europe 2024
Sandoz, Austria Director Regulatory Policy Dr. Thomas Kirchlechner holds a Master’s degree in chemistry from the University of Munich, Germany, and a PhD in chemistry, specializing in marine analytics, from Otago University in Dunedin, New Zealand. In total, he...
by danka | Oct 23, 2023 | Speakers Biosimilars LatAm - Colombia 2024, Speakers Biosimilars LatAm - Europe 2024, Speakers Biosimilars LatAm - Mexico 2023
CECMED, Cuba Regulatory Affairs Specialist Bachelor in Biochemistry and Molecular Biology (2012) and Master in Pharmacology (2016)- Havana University, Cuba. Regulatory Affairs Specialist for biological products with more than 5 years of experience in the evaluation of...
